摘要:
karger.com
sci-hub.se 参考文章(105)
Robert Snoeck, Graciela Andrei, Eric De Clercq, Novel inhibitors of human CMV. Current opinion in investigational drugs. ,vol. 9, pp. 132- 145 ,(2008)
RA Bowden, SJ Slichter, M Sayers, D Weisdorf, M Cays, G Schoch, M Banaji, R Haake, K Welk, L Fisher, A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant Blood. ,vol. 86, pp. 3598- 3603 ,(1995) , 10.1182/BLOOD.V86.9.3598.BLOODJOURNAL8693598
Cynthia A. Bolovan-Fritts, Edward S. Mocarski, Jean A. Wiedeman, Peripheral Blood CD14+ Cells From Healthy Subjects Carry a Circular Conformation of Latent Cytomegalovirus Genome Blood. ,vol. 93, pp. 394- 398 ,(1999) , 10.1182/BLOOD.V93.1.394
Vibha Talwar, Bharat Singh, Piyush Gupta, Atul Kothari, V G Ramachandran, Seroprevalence of cytomegalovirus among voluntary blood donors in Delhi India. Journal of Health Population and Nutrition. ,vol. 20, pp. 348- 351 ,(2002) , 10.3329/JHPN.V20I4.174
Mark A Jacobson, Michael Zegans, Peter R Pavan, James J O'Donnell, Fred Sattler, Narsing Rao, Susan Owens, Richard Pollard, Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy The Lancet. ,vol. 349, pp. 1443- 1445 ,(1997) , 10.1016/S0140-6736(96)11431-8
GwendolynL Gilbert, IreneL Hudson, Kathleen Hayes, Jennifer James, Neonatal Cytomegalovirus Infection Study Group, PREVENTION OF TRANSFUSION-ACQUIRED CYTOMEGALOVIRUS INFECTION IN INFANTS BY BLOOD FILTRATION TO REMOVE LEUCOCYTES The Lancet. ,vol. 333, pp. 1228- 1231 ,(1989) , 10.1016/S0140-6736(89)92330-1
Hermann Einsele, Markus Kapp, Götz Ulrich Grigoleit, CMV-specific T cell therapy. Blood Cells Molecules and Diseases. ,vol. 40, pp. 71- 75 ,(2008) , 10.1016/J.BCMD.2007.07.002
Jan T.M. van der Meer, W.Lawrence Drew, Raleigh A. Bowden, George J. Galasso, Paul D. Griffiths, Douglas A. Jabs, Christine Katlama, Stephen A. Spector, Richard J. Whitley, Summary of the international consensus symposium on advances in the diagnosis, treatment and prophylaxis of cytomegalovirus infection Antiviral Research. ,vol. 32, pp. 119- 140 ,(1996) , 10.1016/S0166-3542(96)01006-6
Glenn A. Van den Bosch, Peter Ponsaerts, Guido Vanham, Dirk R. Van Bockstaele, Zwi N. Berneman, Viggo F. I. Van Tendeloo, Cellular immunotherapy for cytomegalovirus and HIV-1 infection Journal of Immunotherapy. ,vol. 29, pp. 107- 121 ,(2006) , 10.1097/01.CJI.0000184472.28832.D3
Stephen Mackinnon, Kirsty Thomson, Stephanie Verfuerth, Karl Peggs, Mark Lowdell, Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells. Blood Cells Molecules and Diseases. ,vol. 40, pp. 63- 67 ,(2008) , 10.1016/J.BCMD.2007.07.003